SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Board changes

19 May 2026 07:00

RNS Number : 7981E
Caledonia Investments PLC
19 May 2026
Β 

Β 

Caledonia Investments plc

Β 

Board changes

Β 

Caledonia Investments plc ("Caledonia" or the "Company") announces that the board has appointed Will Wyatt as David Stewart's successor as Company Chair. David will retire from the board at the Company's forthcoming annual general meeting (the "AGM"). In addition, The Hon Charles Cayzer has decided not to stand for re-election as a non-executive director at the AGM.

Β 

Will successfully led Caledonia as Chief Executive for over a decade until becoming a non-executive director in July 2022. He is a member of the Cayzer family and has a deep understanding of Caledonia's culture, investment strategy and long-term approach.

Β 

Will's appointment as David's successor follows the completion of a formal, rigorous and transparent process undertaken by the Company's Nomination Committee led by Guy Davison, Senior Independent Director. Major shareholders, who were consulted in advance, confirmed their broad support for Will's appointment.

Β 

David Stewart, Caledonia's Chair, commenting on these changes, said:

Β 

"I am very pleased to announce Will as my successor. He has a unique perspective and long-standing knowledge of the business, which I am sure will serve the Company well as he takes on this new role. I wish him every success.

Β 

Charles has been ever-present on the board of Caledonia since 1985, two years before Caledonia disposed of its stake in British & Commonwealth Holdings Plc. He has helped guide the strategy and has played a key part creating Caledonia's unique culture both as an executive and latterly, as a non-executive director. We shall miss his wisdom and extensive experience and wish him a long and happy retirement after four decades of service.

Β 

On a personal note, it has been an absolute privilege to serve as Chair, and as I step down at this year's AGM, I do so with confidence in Caledonia's future."

Β 

Will Wyatt, non-executive director and Chair elect, commented:

Β 

"It is an honour to be appointed as Chair, and I look forward to continuing to work with the board and management team in this new capacity.

Β 

On behalf of the board, I would like to thank David for his 11 years as a director, nine years of which were as Chair. During this time he led the board through many major events including Brexit, the Covid-19 pandemic and the ensuing turbulence in financial markets.Β His leadership and contribution have helped ensure that Caledonia remains well positioned to execute its long-term strategy."

Β 

19 May 2026

Β 

Enquiries

Β 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

investorrelations@caledonia.com

Β 

David Stewart

Chair

Β 

Guy Davison

Senior Independent Director

Β 

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

Β 

Caledonia Investments plc

Β 

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

Β 

Our aim is to generate long-term compounding real returns that outperform inflation by 3% to 6% over the medium to long term, and the FTSE All-Share index over 10 years.

Β 

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return. The result is a well-balanced diversified portfolio of investments with a global reach.

Β 

For additional information on Caledonia, please visitΒ www.caledonia.com.

Β 

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOASFUFMAEMSEII
Date   Source Headline
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.